Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
170M
-
Number of holders
-
191
-
Total 13F shares, excl. options
-
94.1M
-
Shares change
-
+14.6M
-
Total reported value, excl. options
-
$1.61B
-
Value change
-
+$222M
-
Put/Call ratio
-
0.97
-
Number of buys
-
125
-
Number of sells
-
-71
-
Price
-
$17.09
Significant Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q1 2025
245 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94.1M shares
of 170M outstanding shares and own 55.39% of the company stock.
Largest 10 shareholders include FMR LLC (17.2M shares), Deep Track Capital, LP (9.5M shares), VANGUARD GROUP INC (6.94M shares), T. Rowe Price Investment Management, Inc. (5.89M shares), BAKER BROS. ADVISORS LP (5.46M shares), BlackRock, Inc. (5.36M shares), ARMISTICE CAPITAL, LLC (4.5M shares), STATE STREET CORP (3.09M shares), PERCEPTIVE ADVISORS LLC (2.84M shares), and Alpine Global Management, LLC (2.63M shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.